Max Healthcare Institute Limited (NSE:MAXHEALTH)
1,125.20
-10.00 (-0.88%)
May 30, 2025, 3:30 PM IST
Max Healthcare Institute Revenue
In the fiscal year ending March 31, 2025, Max Healthcare Institute had annual revenue of 70.28B INR with 30.01% growth. Max Healthcare Institute had revenue of 19.10B in the quarter ending March 31, 2025, with 34.21% growth.
Revenue
70.28B
Revenue Growth
+30.01%
P/S Ratio
15.56
Revenue / Employee
3.60M
Employees
19,500
Market Cap
1,093.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 70.28B | 16.22B | 30.01% |
Mar 31, 2024 | 54.06B | 8.43B | 18.49% |
Mar 31, 2023 | 45.63B | 6.26B | 15.90% |
Mar 31, 2022 | 39.37B | 14.29B | 56.96% |
Mar 31, 2021 | 25.08B | 14.49B | 136.82% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Mankind Pharma | 122.07B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 134.58B |
Max Healthcare Institute News
- 8 days ago - Brokerages on Max Healthcare stock: Buy, sell or hold? Check UBS, HSBC calls - Business Upturn
- 8 days ago - HSBC maintains ‘Hold’ on Max Healthcare; sees 7.8% downside amid limited re-rating scope - Business Upturn
- 8 days ago - UBS maintains ‘Buy’ on Max Healthcare, raises target price; sees 18% upside amid expansion-led growth - Business Upturn
- 11 days ago - Stocks to watch on news today: Dr Reddy’s, Sun Pharma, BEL, JSW Steel, NBCC, Max Healthcare, PNC Infra in focus - Business Upturn
- 2 months ago - Pharma and healthcare stocks: Macquarie turns bullish on Sun Pharma, Cipla, Lupin; bearish on Apollo Hospitals, Max Healthcare - Business Upturn
- 2 months ago - Max Healthcare unit merger aims at improved cash flow and reduced compliance burden - Business Upturn
- 2 months ago - Max Healthcare to enter long-term service agreement for New Delhi Hospital - Business Upturn
- 3 months ago - Top stocks to buy: Stock recommendations for the week starting March 3 - The Times of India